Lobbyist
1 client across 1 state · 8 bills
| Client | State | Since | Until |
|---|---|---|---|
| Hy-Vee, Inc. | Minnesota | — | current |
| Bill | Position | For | State | Session |
|---|---|---|---|---|
| HB 238 | — | Pfizer Inc. | Ohio | Sep-Dec13 |
| HB 296 | — | Pfizer Inc. | Ohio | Sep-Dec13 |
| HB 332 | — | Pfizer Inc. | Ohio | Sep-Dec13 |
| HB 93 | — | Pfizer Inc. | Ohio | Sep-Dec12 |
| SB 301 | — | Pfizer Inc. | Ohio | Sep-Dec12 |
| SB 136 | — | Pfizer Inc. | Ohio | Sep-Dec11 |
| HB 238 | — | Pfizer Inc. | Ohio | May-Aug13 |
| HB 334 | — | Pfizer Inc. | Ohio | May-Aug12 |
| SB 301 | — | Pfizer Inc. | Ohio | May-Aug12 |
| HB 341 | — | Pfizer Inc. | Ohio | Jan-Apr14 |
| SB 301 | — | Pfizer Inc. | Ohio | Jan-Apr12 |
No compensation figure appears here because the states involved do not require lobbyists to disclose what they are paid.